Latest Aquaculture News

Oregon Group is seeking effective control of New Zealand King Salmon after agreeing to buy half of a 9.87% stake and secure voting rights over another holder’s shares. The proposed transaction would give Oregon control of 50.68% of NZK’s voting rights, subject to several approvals.

Murray Cod Australia posted a $5.37 million FY2026 loss after the prior year’s $8.56 million profit, despite higher fish biomass and improved fourth-quarter performance. The company ended the year with $4.14 million in cash after raising capital, while operating cash outflow reached $26.57 million and a Westpac interest-cover covenant was breached and waived.

New Zealand King Salmon has raised its FY26 pro-forma EBITDA guidance to $36 million-$39 million, citing better fish performance and lower-than-expected mortality. Harvest volumes are unchanged, while higher feed and wellboat costs are expected to emerge in FY27.

Sea Forest Limited (ASX:SEA) reported a spectacular 486% surge in SeaFeed revenue for FY26, underpinned by 131,000 cattle committed, surpassing breakeven targets, and a robust $27.8 million cash buffer. The company advances its commercial footprint domestically and internationally, with carbon credit revenue set to kick off in late 2027.

Seafarms Group has terminated CEO Peter Fraser for cause and appointed Rod Dyer as CEO on an ongoing, casual basis with hourly remuneration.

Vitrafy Life Sciences reported an 80% revenue surge and halved its net loss, buoyed by US military validation and major blood network partnerships. A $32 million capital raise fuels its US commercial expansion and manufacturing scale-up.

Murray Cod Australia (ASX:MCA) reported a 53% jump in FY26 sales volumes and a 17.9% rise in customer receipts, underpinned by new retail deals with Coles and Woolworths and a focused cost-cutting program.

Sea Forest Limited accelerated its commercial momentum in 4Q26 with an 83% revenue increase to $2.1 million, underpinned by new cattle supply agreements and the commissioning of its first regional distribution centre in Newcastle.

Vitrafy Life Sciences reported a breakthrough 94.4% post-thaw platelet recovery in US Army Phase II testing, secured major US blood network partnerships, and raised $32 million to accelerate US expansion and device manufacturing.

Carnegie Clean Energy has made substantial progress on its ACHIEVE Programme, including module assembly and regulatory approvals for ocean deployment in Spain, supported by a $2.5 million private placement to fund commercial expansion.

Carnegie Clean Energy has secured $2.5 million through a share placement, attracting new overseas investors to fund expansion of its CETO wave energy technology at BiMEP in Spain and commercial activities in Europe and the US.

BPH Global Ltd (ASX: BP8) posted its second best monthly seaweed trading result with gross sales of approximately A$391,000 in the twelfth month, pushing aggregate sales beyond A$3.3 million as Indonesian operations scale up post-monsoon.